Prevalence and Genotype Distribution of Human Papillomavirus Among Attendees at a Sexually Transmitted Diseases Clinic in Urban Tianjin, China

References

• Yilmaz G, Biswas-Fiss EE, Biswas SB. Genetic variations in the DNA replication origins of human papillomavirus family correlate with their oncogenic potential. Biochim Biophys Acta Gen Subj. 2018;1862:979–990. doi:10.1016/j.bbagen.2017.12.010
   PubMed Web of Science ®Google Scholar
• Zur HH. Papillomavirus infections–a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55–F78. doi:10.1016/0304-419x(96)00020-0
   PubMed Web of Science ®Google Scholar
• Georgescu SR, Mitran CI, Mitran MI, et al. New insights in the pathogenesis of HPV infection and the associated carcinogenic processes: the role of chronic inflammation and oxidative stress. J Immunol Res. 2018;2018:1–10. doi:10.1155/2018/5315816
   Web of Science ®Google Scholar
• Sudenga SL, Ingles DJ, Campbell CMP, et al. Genital human papillomavirus infection progression to external genital lesions: the HIM Study. Eur Urol. 2016;69:166–173. doi:10.1016/j.eururo.2015.05.032
   PubMed Web of Science ®Google Scholar
• Serrano B, Brotons M, Bosch FX, et al. Epidemiology and burden of HPV-related disease. Best Pract Res Clin Obstet. 2018;47:14–26. doi:10.1016/j.bpobgyn.2017.08.006
   PubMed Web of Science ®Google Scholar
• Chibwesha CJ, Stringer JSA. Cervical cancer as a global concern: contributions of the dual epidemics of HPV and HIV. J Am Med Assoc. 2019;322:1558–1560. doi:10.1001/jama.2019.16176
   Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141:664–670. doi:10.1002/ijc.30716
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolesc Health. 2010;461:S20–S26. doi:10.1002/ijc.30716
   Web of Science ®Google Scholar
• Moghoofei M, Keshavarz M, Ghorbani S, et al. Association between human papillomavirus infection and prostate cancer: a global systematic review and meta-analysis. Asia Pac J Clin Oncol. 2019;15:E59–E67. doi:10.1111/ajco.13124
   PubMed Web of Science ®Google Scholar
• Bruni L, Albero G, Serrano B, et al. ICO/IARC information centre on HPV and Cancer (HPV information centre). Human papillomavirus and related diseases in China. Summary Report 17 June 2019. Available from: https://hpvcentre.net/statistics/reports/CHN.pdf?t=1617614054427., Accessed April 5, 2021.
   Google Scholar
• Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20(3):319–321. doi:10.1016/S1470-2045(19)30072-5
   PubMed Web of Science ®Google Scholar
• World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations. Vaccine. 2017;35(43):5753–5755. doi:10.1016/j.vaccine.2017.05.069
   PubMed Web of Science ®Google Scholar
• World Health Organization. Vaccine introduction slides; 2020.
   Google Scholar
• Hu S, Xu X, Zhang Y, et al. A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: implications for vaccine roll-out in mainland China. Vaccine. 2021;39(1):35–44. doi:10.1016/j.vaccine.2020.11.029
   PubMed Web of Science ®Google Scholar
• Ciavattini A, Giannella L, De Vincenzo R, et al. HPV vaccination: the position paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Vaccines (Basel). 2020;8(3). doi:10.3390/vaccines8030354
   Web of Science ®Google Scholar
• Qiao YL, Wu T, Li CR, et al. Efficacy, safety, and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine: an interim analysis of a randomised clinical trial. J Natl Cancer Inst. 2019;112:145–153. doi:10.1093/jnci/djz074
   Google Scholar
• Zhu FC, Chen W, Hu YM, et al. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: results from a randomized controlled trial. Int J Cancer. 2014;135:2612–2622. doi:10.1002/ijc.28897
   PubMed Web of Science ®Google Scholar
• Hu YM, Guo M, Li CG, et al. Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young women. Sci China Life Sci. 2020;63:582–591. doi:10.1007/s11427-019-9547-7
   PubMed Web of Science ®Google Scholar
• Trottier H, Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Am J Manag Care. 2006;12S:S462–S472.
   Google Scholar
• Wang R, Guo X, Wisman GBA, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China. Bmc Infect Dis. 2015;15. doi:10.1186/s12879-015-0998-5
   Web of Science ®Google Scholar
• Chen X, Wallin K, Duan M, et al. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China. J Med Virol. 2015;87:1966–1972. doi:10.1002/jmv.24248
   PubMed Web of Science ®Google Scholar
• Wang J, Tang D, Wang K, et al. HPV genotype prevalence and distribution during 2009–2018 in Xinjiang, China: baseline surveys prior to mass HPV vaccination. Bmc Womens Health. 2019;19. doi:10.1186/s12905-019-0785-3
   Web of Science ®Google Scholar
• Li B, Wang H, Yang D, et al. Prevalence and distribution of cervical human papillomavirus genotypes in women with cytological results from Sichuan province, China. J Med Virol. 2019;91:139–145. doi:10.1002/jmv.25255
   PubMed Web of Science ®Google Scholar
• Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China’s largest CAP certified laboratory. J Cancer. 2016;7:1037–1043. doi:10.7150/jca.14971
   PubMed Web of Science ®Google Scholar
• Xin HN, Li HJ, Li Z, et al. Genital HPV infection among heterosexual and homosexual male attendees of sexually transmitted diseases clinic in Beijing, China. Epidemiol Infect. 2017;145:2838–2847. doi:10.1017/S0950268817001698
   PubMed Web of Science ®Google Scholar
• Ingles DJ, Lin H, Fulp WJ, et al. An analysis of HPV infection incidence and clearance by genotype and age in men: the HPV Infection in Men (HIM) Study. Papillomavirus Res. 2015;1:126–135. doi:10.1016/j.pvr.2015.09.001
   PubMedGoogle Scholar
• Tao G, Yaling G, Zhan G, et al. Human papillomavirus genotype distribution among HPV-positive women in Sichuan province, Southwest China. Arch Virol. 2018;163:65–72. doi:10.1007/s00705-017-3556-1
   PubMed Web of Science ®Google Scholar
• Hong H, He T, Ni H, et al. Prevalence and genotype distribution of HPV infection among women in Ningbo, China. Int J Gynecol Obstet. 2015;131:96–99. doi:10.1016/j.ijgo.2015.04.027
   PubMed Web of Science ®Google Scholar
• Dai M, Bao YP, Li N, et al. Human papillomavirus infection in Shanxi Province, People’s Republic of China: a population-based study. Br J Cancer. 2006;95:96–101. doi:10.1038/sj.bjc.6603208
   PubMed Web of Science ®Google Scholar
• Zhang J, Cheng K, Wang Z. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis. Arch Gynecol Obstet. 2020;302(6):1329–1337. doi:10.1007/s00404-020-05787-w
   PubMed Web of Science ®Google Scholar
• Giannella L, Fodero C, Boselli F, et al. Age-related changes in the diagnostic assessment of women with severe cervical lesions. Climacteric. 2015;18(4):617–623. doi:10.3109/13697137.2015.1005592
   PubMed Web of Science ®Google Scholar
• Giannella L, Fodero C, Boselli F, et al. Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2017;137(1):72–77. doi:10.1002/ijgo.12106
   PubMed Web of Science ®Google Scholar
• Giannella L, Delli CG, Di Giuseppe J, et al. Age-related changes in the fraction of cervical intraepithelial neoplasia grade 3 related to HPV genotypes included in the nonavalent vaccine. J Oncol. 2019;2019:713789. doi:10.1155/2019/7137891
   Web of Science ®Google Scholar
• Li X, Li M, Yang Y, et al. Anal HPV/HIV co-infection among men who have sex with men: a cross-sectional survey from three cities in China. Sci Rep. 2016;6. doi:10.1038/srep21368
   Web of Science ®Google Scholar
• Zhang D, Yin Y, Feng T, et al. HPV infections among MSM in Shenzhen, China. PLoS One. 2014;9. doi:10.1371/journal.pone.0096364
   Web of Science ®Google Scholar
• Zhu C, Wang Y, Mao W, et al. Prevalence and distribution of HPV types in genital warts in Xi’an, China: a prospective study. BMJ Open. 2019;9:e023897. doi:10.1136/bmjopen-2018-023897
   PubMed Web of Science ®Google Scholar
• Lee SA, Kang D, Seo SS, et al. Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett. 2003;198:187–192. doi:10.1016/s0304-3835(03)00312-4
   PubMed Web of Science ®Google Scholar
• Goodman MT, McDuffie K, Hernandez BY, et al. The influence of multiple human papillomavirus types on the risk of genotype-concordant incident infections of the Anus and Cervix: the Hawaii HPV Cohort Study. J Infect Dis. 2011;203:335–340. doi:10.1093/infdis/jiq058
   PubMed Web of Science ®Google Scholar